ORTEXORTEX News
Tracking ADC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AD
Earnings PreviewADC

ADC: Analysts Cut Again as Shorts Ease After the Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 24 Oct 2026, 04:02

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Agree Realty closed Friday at $66.70, down half a percent on the week, while its closest net lease peers gained a median 1.0%. NNN added 0.4%, O rose 1.4%, and KIM was up 3.1% over the same stretch.

Short interest has pulled back from its October peak, now at 7.6 million shares or 6.6% of the free float, after touching 8.1 million on October 20. That is still up 23% over the past month, but the pace of accumulation has clearly slowed. Borrow costs are 0.42% and availability is 379%, meaning nearly four shares remain available to borrow for every one already shorted. There is no mechanical pressure building in the lending market. The ORTEX short score has also drifted lower through the week, falling from 54.7 on October 9 to 51.7 on October 22, a modest retreat from the elevated readings that preceded the Q3 print.

The analyst community has been the more decisive mover. In the four trading days since the Q3 results landed, Citigroup cut its target to $72 from $82.50 (keeping Neutral), BNP Paribas trimmed to $74 from $84, Stifel shaved to $76.50 from $81.50, and Baird edged down to $76 from $77. Barclays and Wells Fargo had already moved lower before the print. The mean target across the coverage universe now stands at $78.53, implying roughly 18% above the current price on paper. Every recent move has been a target reduction, none a rating cut, which frames the Street's view precisely: the business is fine, the valuation entry point has shifted. The bull case rests on Q3 AFFO of $1.15, up 4.9% year over year and ahead of expectations, a high-quality tenant roster weighted toward investment-grade and e-commerce-resistant retail, and what the company describes as a strong cost of capital. Bears point to a 2027 AFFO multiple of 16x to 17x that leaves little room for disappointment, plus a $400 million note offering priced at a 5.849% yield-to-maturity, a reminder that financing costs have not returned to the pre-rate-rise era.

The insider picture established in the weeks before the print remains relevant context. Director John Rakolta Jr. spent roughly $2.1 million across three open-market purchases in August and September. CEO Joey Agree bought 7,360 shares at $68.06 on September 16. Chief Growth Officer Craig Erlich added 1,000 shares at $67.55 on September 21. None were pre-arranged 10b5-1 trades. Net insider buying over the past 90 days totals around $4.1 million. The stock is now trading below the price levels at which most of that buying occurred, which means those positions are underwater at $66.70.

The October 27 event is a second look at the same numbers: Q3 results are already public. What the next filing will test is whether the guidance commentary and balance sheet detail released alongside those results has changed how much of the target-price gap analysts are willing to close, and whether the short position that built so rapidly in early October continues to unwind or stabilises at current levels.

Stocks in this article

See the live data behind this article on ORTEX.

Open ADC on ORTEX →

How this article was generated

Generated
24 Oct 2026, 04:23
Data as of
24 Oct 2026, 04:02
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.